Crossmark

Challenge following discontinuation of incretin-based anti-obesity drugs: weight relapse and prevention strategies

Published Online: 2026-07-05

Authors

Shil, Kishore Kumar https://orcid.org/0000-0002-6664-6408
License Information

Text and Data Mining valid from 2026-07-05

Version of Record valid from 2026-09-25
More Information

Article History

Received: 10 February 2026

Accepted: 29 June 2026

First Online: 5 July 2026

Declarations

Ethics approval and consent to participate: Not applicable.

Competing interests: The authors declare no competing interests.

Document is current